Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Prognostic factors for stage IV gastric cancer.

Baba H, Kuwabara K, Ishiguro T, Kumamoto K, Kumagai Y, Ishibashi K, Haga N, Ishida H.

Int Surg. 2013 Apr-Jun;98(2):181-7. doi: 10.9738/INTSURG-D-12-00027.1. No abstract available.

2.

Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.

Zhu Y, Sun Y, Hu S, Jiang Y, Yue J, Xue X, Yang L, Xue L.

BMC Gastroenterol. 2017 Mar 14;17(1):41. doi: 10.1186/s12876-017-0598-5.

3.

Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1.

Aoyama T, Yoshikawa T, Watanabe T, Hayashi T, Ogata T, Cho H, Tsuburaya A.

Gastric Cancer. 2011 Aug;14(3):274-8. doi: 10.1007/s10120-011-0038-0. Epub 2011 Apr 2.

PMID:
21461654
4.

Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.

Lee SJ, Sohn TS, Lee J, Park SH, Park JO, Lim DH, Park YS, Lim HY, Choi MG, Lee JH, Bae JM, Kim S, Kang WK.

Anticancer Res. 2014 Nov;34(11):6585-91.

PMID:
25368262
5.

Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.

Okuyama T, Korenaga D, Edagawa A, Itoh S, Oki E, Kawanaka H, Ikeda Y, Kakeji Y, Tateishi M, Tsujitani S, Takenaka K, Maehara Y.

Surg Today. 2012 Aug;42(8):734-40. doi: 10.1007/s00595-012-0129-5. Epub 2012 Jan 27.

PMID:
22278622
6.

Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.

Fukuchi M, Ishiguro T, Ogata K, Suzuki O, Kumagai Y, Ishibashi K, Ishida H, Kuwano H, Mochiki E.

Ann Surg Oncol. 2015 Oct;22(11):3618-24. doi: 10.1245/s10434-015-4422-6. Epub 2015 Feb 7.

PMID:
25663597
7.
8.

Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase II study.

Yoshikawa T, Tanabe K, Nishikawa K, Ito Y, Matsui T, Kimura Y, Hasegawa S, Aoyama T, Hayashi T, Morita S, Miyashita Y, Tsuburaya A, Sakamoto J.

Ann Surg Oncol. 2014 Jun;21 Suppl 3:S385-9. doi: 10.1245/s10434-014-3615-8. Epub 2014 Mar 5.

PMID:
24595801
9.

Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.

Baba H, Yamamoto M, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T.

Gastric Cancer. 2003;6 Suppl 1:45-9.

PMID:
12775020
10.

Human epidermal growth factor receptor 2 (Her-2) and S-1 adjuvant chemotherapy in stage 2/3 gastric cancer patients who underwent D2 gastrectomy.

Aoyama T, Yoshikawa T, Miyagi Y, Kameda Y, Shirai J, Hayashi T, Cho H, Oshima T, Yukawa N, Rino Y, Masuda M, Tsuburaya A.

Surg Today. 2013 Dec;43(12):1390-7. doi: 10.1007/s00595-013-0544-2. Epub 2013 Mar 20.

PMID:
23512532
11.

Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.

Kinoshita J, Fushida S, Tsukada T, Oyama K, Okamoto K, Makino I, Nakamura K, Miyashita T, Tajima H, Takamura H, Ninomiya I, Ohta T.

Eur J Surg Oncol. 2015 Oct;41(10):1354-60. doi: 10.1016/j.ejso.2015.04.021. Epub 2015 May 15.

12.

[Prognostic factors and usefulness of chemotherapy with S-1 in patients received gastrectomy for stage IV gastric cancer].

Maehara N, Hidaka H, Nagaike K, Nakashima S, Hotokezaka M, Chijiiwa K.

Gan To Kagaku Ryoho. 2009 Jul;36(7):1111-4. Japanese.

PMID:
19620798
13.

Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.

Kunisaki C, Makino H, Kimura J, Takagawa R, Kanazawa A, Ota M, Kosaka T, Ono HA, Akiyama H, Endo I.

Oncology. 2015;88(5):281-8. doi: 10.1159/000369497. Epub 2015 Jan 14.

PMID:
25591954
14.

Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.

Aoyama T, Yoshikawa T, Shirai J, Hayashi T, Yamada T, Tsuchida K, Hasegawa S, Cho H, Yukawa N, Oshima T, Rino Y, Masuda M, Tsuburaya A.

Ann Surg Oncol. 2013 Jun;20(6):2000-6. doi: 10.1245/s10434-012-2776-6. Epub 2012 Dec 16.

PMID:
23242818
15.

Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.

Ruf C, Thomusch O, Goos M, Makowiec F, Illerhaus G, Ruf G.

BMC Surg. 2014 Jan 24;14:5. doi: 10.1186/1471-2482-14-5.

16.

Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.

Inoue T, Yachida S, Usuki H, Kimura T, Hagiike M, Okano K, Suzuki Y.

Ann Surg Oncol. 2012 Sep;19(9):2937-45. doi: 10.1245/s10434-012-2332-4. Epub 2012 Mar 31.

PMID:
22466666
17.

Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study.

Kanda T, Yajima K, Kosugi S, Ishikawa T, Ajioka Y, Hatakeyama K.

Gastric Cancer. 2012 Jul;15(3):235-44. doi: 10.1007/s10120-011-0100-y. Epub 2011 Oct 28.

PMID:
22033890
18.

A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.

Park I, Ryu MH, Choi YH, Kang HJ, Yook JH, Park YS, Kim HJ, Jung HY, Lee GH, Kim KC, Kim BS, Kang YK.

Cancer Chemother Pharmacol. 2013 Oct;72(4):815-23. doi: 10.1007/s00280-013-2257-z. Epub 2013 Aug 7.

PMID:
23921575
19.

Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.

Kanda M, Murotani K, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Surgery. 2015 Dec;158(6):1573-80. doi: 10.1016/j.surg.2015.05.017. Epub 2015 Jun 25.

PMID:
26120068
20.

[Preoperative S-1/CDDP combination chemotherapy was effective in a case of local advanced gastric cancer].

Takada J, Watanabe K, Kuraya D, Kina M, Hayashi S, Hamada H, Katsuki Y.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2451-4. Japanese.

PMID:
21224603

Supplemental Content

Support Center